I am/have/had
I am looking for
Advanced Filters
Found 2 clinical trials
Bevacizumab Combined With Gefitinib in the Treatment of Advanced NSCLC
To compare the efficacy and safety of gefitinib combined with bevacizumab and gefitinib in the treatment of L858R positive mutation in exon 21 of EGFR gene in advanced NSCLC.
egfr gene
ejection fraction
non-small cell lung cancer
bevacizumab
sputum cytology
- 0 views
- 05 Aug, 2020
Clinical Trial of YH25448(Lazertinib) as the First-line Treatment in Patients With EGFR Mutation Positive Locally Advanced or Metastatic NSCLC (LASER301)
This Phase III study will be conducted to evaluate the efficacy and safety of YH25448 as first-line treatment in locally advanced or metastatic Non-small Cell Lung Cancer (NSCLC) patients with EGFR mutations
EGFR
lung adenocarcinoma
adenocarcinoma
gefitinib
lazertinib
- 0 views
- 16 Feb, 2024
- 29 locations